Core A will provide leadership, management, organizational structure, fiscal oversight, and scientific direction to the Penn Mental Health AIDS Research Center (PMHARC), enabling it to fulfill its core mission to transform how people with both mental illness and HIV/AIDS (mental illness/AIDS) are treated and managed, an explicit focus not currently pursued by any other center in the country. The Center and Gore A will be led by a Director and two Go-Directors with exceptional and complementary strengths and experience in administration, research, and training and in the study of comorbid mental illness/AIDS. PMHARG will be located in an optimal intellectual and resource environment, which encompasses robust and well-regarded mental illness and AIDS research communities on the University of Pennsylvania and Children's Hospital of Philadelphia contiguous campuses. The Center, through Gore A, will optimize psychiatric, behavioral, and medical outcomes for those suffering from comorbid mental illness/AIDS and elucidate the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments. Gore A will create an interactive environment that fosters communication, collaboration, and synergy among Center components and participants, as well as with the relevant schools, departments, centers, and institutes at Penn/CHOP and with other NIMH AIDS Research Centers. This proactive Core will be engaged and responsible for: 1) coordinating interdisciplinary and collaborative mental health and AIDS research activities;2) encouraging, supporting, and mentoring new, established, and transitional investigators to focus on comorbid mental illness/AIDS, and related comorbidities;3) developing vibrant and responsive Strategic Planning, Monitoring, and Evaluation Processes and comprehensive Policies and Procedures;4) managing fiscal matters;5) conducting educational and community outreach programs;6) fostering national linkages among other NIMH AIDS Research Centers;and 7) establishing an active Community Advisory Board (GAB). Core A will include the Center Director, 2 Co-Directors, Executive Committee (EC), Internal Advisory Board (lAB), External Advisory Committee (EAC), Gross-Talk Committee, and CAB. This structure of Gore A is explicitly intended to allow for continuous monitoring and evaluation of PMHARC functioning in order to optimize efficiencies and responsiveness.

Public Health Relevance

Gore A will provide leadership, management, organizational structure, fiscal oversight, and scientific direction to the proposed Center, enabling it to transform how people with both mental illness and HIV/AIDS are treated and managed, an explicit focus not currently pursued by any other center in the country. The Center, through Gore A, will optimize psychiatric, behavioral, and medical outcomes for those suffering from comorbid mental illness/AIDS and elucidate the biological, psychological, and behavioral mechanisms underlying these combined illnesses and treatments

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
1P30MH097488-01A1
Application #
8604527
Study Section
Special Emphasis Panel (ZMH1-ERB-M (02))
Project Start
Project End
Budget Start
2013-06-03
Budget End
2014-05-31
Support Year
1
Fiscal Year
2013
Total Cost
$303,432
Indirect Cost
$113,787
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Dowshen, Nadia; Matone, Meredith; Luan, Xianqun et al. (2016) Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care. LGBT Health 3:162-7
Barrett, Jeffrey S; Spitsin, Sergei; Moorthy, Ganesh et al. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. J Transl Med 14:148
Douglas, Steven D (2016) Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches. Br J Haematol 175:187-188
Lyons, Anita; Bilker, Warren B; Hines, Janet et al. (2016) Effect of format on comprehension of adherence data in chronic disease: A cross-sectional study in HIV. Patient Educ Couns 99:154-9
McGuire, Jennifer L; Gill, Alexander J; Douglas, Steven D et al. (2016) The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth. J Neurovirol 22:823-830
Greeson, Jeffrey M; Gettes, David R; Spitsin, Sergei et al. (2016) The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells. Biol Psychiatry 80:33-9
McGuire, Jennifer L; Gill, Alexander J; Douglas, Steven D et al. (2015) Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol 21:439-48
Springer, Sandra A; Larney, Sarah; Alam-Mehrjerdi, Zahra et al. (2015) Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions. J Acquir Immune Defic Syndr 69 Suppl 2:S155-61
Yehia, Baligh R; Stephens-Shield, Alisa J; Momplaisir, Florence et al. (2015) Health Outcomes of HIV-Infected People with Mental Illness. AIDS Behav 19:1491-500
McGuire, Jennifer L; Kempen, John H; Localio, Russell et al. (2015) Immune markers predictive of neuropsychiatric symptoms in HIV-infected youth. Clin Vaccine Immunol 22:27-36

Showing the most recent 10 out of 23 publications